rp-1,nivolumab,vusolimogene,rp2
bms,replimune
['rp1', 'ignyte', 'melanoma', 'rp2 ', '$repl', 'replimune']
$repl - replimune presents rp1 data from the ignyte anti-pd1 failed melanoma cohort and rp2 data in uveal melanoma at the 2023 american society of clinical oncology (asco) annual meeting 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.